For brand & commercialization teams
We come prepared, not curious.
Most consultants arrive to learn your business. RxPx arrives having already mapped your molecule, your market, and where programs like yours tend to break down, before the first conversation.
- Faster time to treatment
- From 6 weeks to 11-16 days
- 74%
- Average PSPs adherence rate
- Sustained across MS drug program
- 90%
- Patient satisfaction rating
- Across all program types
- 92%
- HCP accounts active
- After 1 year in liver monitor program
- 91%
The execution gap
The program looks right on paper.The real world disagrees.
1 in 3 clinically differentiated launches still fail to meet expectations.* The gap isn’t the science. It’s the decisions made or not made in the 24 months before launch. RxPx embeds with your brand team before the risks are visible, designing the commercialization infrastructure that most programs only try to fix after launch day.
We build onboarding journeys and PSP workflow design.
From insights to impact.
RxPx advisory engagements help you make confident decisions early, design the right operational model, and accelerate execution, all without the translation risk of a generalist handoff.
Explore advisory services- Program health score
- 82/100
- Critical risks
- 3
- Top opportunity
- $2.4M
Strategic audit
Top-level audit of your program, including where value is being lost, and why. We bring benchmarks and audit tools so you get to insight faster than starting from scratch.
Operational blueprint
Design workshops solving gaps from Phase 1 – safety monitoring, vendor ecosystem, affiliate readiness, governance. Built for your indication, not another industry.
Investment alignment
Translate findings into a structured investment recommendation. We build the case your CFO, medical director, and compliance team each need to say yes.
Workshops that drive smarter decisions.
Problem-led sessions designed to solve your most pressing commercialisation challenges. Tangible deliverable every time. Priced to move fast.
Why RxPx.
Operational commercialization expertise. Implementation-ready strategy. The same team that designs your model is the team that builds it.
Strategy without execution depth
Theoretical frameworks
Disconnected handoffs
Slow operational understanding
Limited real-world visibility
Operational commercialization expertise
Implementation-ready strategy
Real-world therapy infrastructure
Safety-grade execution experience
Launch-to-persistence visibility
Measurable impact across the commercialization journey.
66%
Reduction in FTE hours required
for lab coordination
96%
Adherence in trials
92%
Adherence in real world settings
50%
HCPs voluntarily enrolled in first 12 months
Based on RxPx safety monitoring data.
Shape the brief
before it’s written.
The brand managers who get the best outcomes engage RxPx before the budget is set. That’s when we can do the most. Start with a workshop. Fast to approve. Real output from day one.
*ZS Associates, 2025 — study of 340 drug launches.